Neratinib Maleate
Spécifications
915942-22-2Numéro CAS
620-527-5Numéro CE
(Z)-but-2-enedioic acid;(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamideNom IUPAC
C34H33ClN6O7Formule chimique
673.1 g/molMasse molaire
Neratinib maleate; 915942-22-2; hki-272 maleate; 9RM7XY23ZS; NERATINIB MALEATE ANHYDROUS; DTXSID801027861; 2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, (2Z)-2-butenedioate (1:1); RefChem:56994; DTXCID701513439; Neratinib maleate [MI]; Nerlynx; Neratinib (maleate); MFCD30607264; (E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide Maleate; (Z)-but-2-enedioic acid;(E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide; C34H33ClN6O7; UNII-9RM7XY23ZS; 915942-22-2 (maleate); Nerlynx (TN); orb1944868; SCHEMBL2180998; CHEMBL3989921; SCHEMBL29576434; SCHEMBL29576438; SCHEMBL30276894; GLXC-22738; NERATINIB MALEATE [WHO-DD]; HY-32721B; AKOS030524209; EBC-102064; NERATINIB MALEATE [ORANGE BOOK]; (2E)-N-(4-{[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino}-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-2-butenamide (2Z)-2-butenedioate (1:1); (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide maleate; BN160240; DS-19892; SY247493; DB-210727; CS-0030935; D10898; D71134; T67385; F835741; Q27272985; (E)-N-[4-[3-chloro-4-(2-pyridylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolyl]-4-(dimethylamino)but-2-enamide;maleic acid; (E)-N-[4-[3-Chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide MaleateSynonymes
